<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="abstract"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur Psychiatry</journal-id><journal-id journal-id-type="iso-abbrev">Eur Psychiatry</journal-id><journal-id journal-id-type="publisher-id">EPA</journal-id><journal-title-group><journal-title>European Psychiatry</journal-title></journal-title-group><issn pub-type="ppub">0924-9338</issn><issn pub-type="epub">1778-3585</issn><publisher><publisher-name>Cambridge University Press</publisher-name><publisher-loc>Cambridge, UK</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11862667</article-id><article-id pub-id-type="doi">10.1192/j.eurpsy.2024.534</article-id><article-id pub-id-type="other">EPP0365</article-id><article-id pub-id-type="pii">S0924933824005340</article-id><article-categories><subj-group subj-group-type="heading"><subject>Abstract</subject></subj-group><subj-group subj-group-type="section"><subject>e-Poster Presentation</subject></subj-group></article-categories><title-group><article-title>Korean Medication Algorithm for Bipolar Disorder: changes in preferred medications for mania over 20 years</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Jon</surname><given-names>D.-I.</given-names></name><xref rid="aff1203" ref-type="aff">
<sup>1</sup>
</xref><xref rid="cor0395" ref-type="corresp">
<sup>*</sup></xref></contrib><contrib contrib-type="author"><name><surname>Woo</surname><given-names>Y. S.</given-names></name><xref rid="aff1204" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Jeong</surname><given-names>J.-H.</given-names></name><xref rid="aff1204" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Seo</surname><given-names>J.-S.</given-names></name><xref rid="aff1205" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Lee</surname><given-names>J. G.</given-names></name><xref rid="aff1206" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Yoon</surname><given-names>B.-H.</given-names></name><xref rid="aff1207" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Sohn</surname><given-names>I.</given-names></name><xref rid="aff1208" ref-type="aff">
<sup>6</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Bahk</surname><given-names>W.-M.</given-names></name><xref rid="aff1204" ref-type="aff">
<sup>2</sup>
</xref></contrib></contrib-group><aff id="aff1203">
<sup>1</sup><institution>Hallym University Sacred Heart Hospital</institution>, <city>Anyang</city>
</aff><aff id="aff1204">
<sup>2</sup><institution>The Catholic University</institution>
</aff><aff id="aff1205">
<sup>3</sup><institution>Joongang University</institution>, <city>Seoul</city>
</aff><aff id="aff1206">
<sup>4</sup><institution>Inje University</institution>, <city>Busan</city>
</aff><aff id="aff1207">
<sup>5</sup><institution>Naju National Hospital</institution>, <city>Naju</city>
</aff><aff id="aff1208">
<sup>6</sup><institution>Kyeyo Hospital</institution>, <city>Euwang</city>, <country>Korea</country>, Republic Of</aff><author-notes><corresp id="cor0395">
<label>*</label>Corresponding author.</corresp></author-notes><pub-date publication-format="electronic" date-type="collection" iso-8601-date="2024-04"><month>4</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>27</day><month>8</month><year>2024</year></pub-date><volume>67</volume><issue seq="509">Suppl 1</issue><issue-title content-type="special_issue">Abstracts of the 32nd European Congress of Psychiatry</issue-title><fpage>S251</fpage><lpage>S252</lpage><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>The Author(s)</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (<uri xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="S0924933824005340a.pdf"/><abstract><sec id="sec2371"><title>Introduction</title><p>
Majority of international guidelines for bipolar disorders are based on evidences from clinical trials. In contrast, the Korean Medication Algorithm Project for Bipolar Disorder (KMAP-BP) was developed to adopt an expert-consensus paradigm which was more practical and specific to the atmosphere in Korea.</p></sec><sec id="sec2372"><title>Objectives</title><p>In this study, preferred medication strategies for acute mania over six consecutively published KMAP-BP (2002, 2006, 2010, 2014, 2018, and 2022) were investigated.</p></sec><sec id="sec2373"><title>Methods</title><p>A written survey using a nine-point scale was asked to Korean experts about the appropriateness of various treatment strategies and treatment agents. A written survey asked about the appropriateness of various treatment strategies and treatment agents commonly used by clinicians as the first-line.</p></sec><sec id="sec2374"><title>Results</title><p>The most preferred option for the initial treatment of mania was a combination of a mood stabilizer (MS) and an atypical antipsychotic (AAP) in every edition. Preference for combined treatment for euphoric mania increased, peaked in KMAP-BP 2010, and declined slightly. Either MS or AAP monotherapy was also considered a first-line strategy for mania, but not for all types of episodes, including mixed/psychotic mania. Among MSs, lithium and valproate are almost equally preferred except in the mixed subtype where valproate is the most recommended MS. The preference of valproate showed reverse U-shaped curve. This preference change of valproate may indicate the concern about teratotoxicity in women. Quetiapine, aripiprazole, and olanzapine were the preferred AAP for acute mania since 2014. This change might depend on the recent evidences and safety profile. In cases of unsatisfactory response to initial medications, switching or adding another first-line agent was recommended. The most notable changes over time included the increasing preference for AAPs.</p></sec><sec id="sec2375"><title>Conclusions</title><p>The Korean experts have been increasingly convinced of the effectiveness of a combination therapy for acute mania. There have been evident preference changes: increased for AAP and decreased for carbamazepine.</p></sec><sec id="sec2376"><title>Disclosure of Interest</title><p>None Declared</p></sec></abstract><counts><page-count count="2"/></counts></article-meta></front></article>